FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Dr Reddys Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500124 P/E (TTM) :19.27
ISIN Demat:INE089A01031 Div & Yield %:0.64 EPS (TTM) :64.68
Book Value (RS) :377.5672424 Market Cap (Rs Cr.):104014.67 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 4,602.90 6,678.80 -31.08
Other Income 364.20 207.60 75.43
PBIDT 844.50 2,929.20 -71.17
Interest 33.40 28.40 17.61
PBDT 811.10 2,900.80 -72.04
Depreciation 294.80 260.00 13.38
PBT 516.30 2,640.80 -80.45
Tax 77.70 703.30 -88.95
Deferred Tax 51.30 55.40 -7.40
PAT 387.30 1,882.10 -79.42

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)